Crosses blood-brain barrier
Well-absorbed orally but bioavailability varies widely (30-90%) due to variable first-pass metabolism
D2 antagonism
Prokinetic effects on stomach
5-HT3 antagonism at high doses
Uraemia, radiation, gastrointestinal disorders, cytotoxic drugs